Current Daily Chart:

Chelsea Therapeutics (Nasdaq: CHTP ) is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera(TM) (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure. For more information about the Company, visit http://www.chelseatherapeutics.com

http://www.otcmarkets.com/stoc…..mpany-info

Looks like as good a place as any to see a bounce on CHTP. Overall still nice and bullish.